Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -235,110 (Position Closed) | Filing History |
| 2022-02-14 1:46 pm Purchase | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 345,707 7.530% | 345,707 (New Position) | Filing History |
| 2022-02-14 06:05 am Sale | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | Nikko Asset Management Americas, Inc. | 39,276 0.860% | -251,904 (-86.51%) | Filing History |
| 2022-02-11 3:11 pm Purchase | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | JANUS HENDERSON GROUP PLC JHG | 252,755 5.500% | 252,755 (New Position) | Filing History |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | The Vanguard Group | 233,813 5.090% | 233,813 (New Position) | Filing History |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 688,854 14.999% | 122,025 (+21.53%) | Filing History |
| 2022-02-04 06:09 am Sale | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | Sumitomo Mitsui Trust Group Inc. | 39,276 0.850% | -251,904 (-86.51%) | Filing History |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 293,135 6.400% | -20,557 (-6.55%) | Filing History |
| 2022-01-10 10:46 am Sale | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | STATE STREET CORP STT | 239,279 5.210% | -260,890 (-52.16%) | Filing History |
| 2021-10-12 12:39 pm Purchase | 2021-09-30 | 13G | Seres Therapeutics, Inc. MCRB | STATE STREET CORP STT | 500,170 10.910% | 500,170 (New Position) | Filing History |
| 2021-05-05 4:39 pm Purchase | 2021-04-27 | 13G | Seres Therapeutics, Inc. MCRB | RA CAPITAL MANAGEMENT L.P. | 235,110 5.100% | 235,110 (New Position) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB | ARK Investment Management LLC | 687,063 15.060% | 72,411 (+11.78%) | Filing History |
| 2021-02-11 5:26 pm Purchase | 2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB | Nikko Asset Management Americas, Inc. | 291,180 6.380% | 9,931 (+3.53%) | Filing History |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 566,829 12.423% | 26,804 (+4.96%) | Filing History |
| 2021-02-05 06:10 am Purchase | 2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB | Sumitomo Mitsui Trust Group Inc. | 291,180 6.380% | 9,931 (+3.53%) | Filing History |
| 2021-02-01 08:30 am Purchase | 2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB | BlackRock Inc. BLK | 313,692 6.900% | 113,524 (+56.71%) | Filing History |
| 2020-11-25 4:30 pm Sale | 2020-11-23 | 13D | Seres Therapeutics, Inc. MCRB | Flagship VentureLabs IV LLC | 752,500 16.500% | -329,846 (-30.48%) | Filing History |
| 2020-10-09 2:17 pm Purchase | 2020-06-30 | 13G | Seres Therapeutics, Inc. MCRB | ARK Investment Management LLC | 614,652 13.770% | 250,960 (+69.00%) | Filing History |
| 2020-09-10 10:03 am Purchase | 2020-09-09 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 540,025 12.095% | 215,069 (+66.18%) | Filing History |
| 2020-09-09 06:03 am Sale | 2020-08-31 | 13G | Seres Therapeutics, Inc. MCRB | Sumitomo Mitsui Trust Group Inc. | 281,250 6.300% | -132,412 (-32.01%) | Filing History |